In Silico Design and Optimisation of Phytoalexin Resveratrol Polyphenolic Analogs as Inhibitors of Histone Acetyltransferase for the Management of Tumor Growth

Journal Title: UNKNOWN - Year 2018, Vol 8, Issue 8

Abstract

Cancer cells are known to be more susceptible to deoxyribonucleic acid (DNA) damage than normal ones due to their genetic instability. The post-translation modification of histones plays a crucial role in chromatin regulation, influencing gene expression, DNA replication and repair. Histone acetyl transferases (HAT) are enzymes that acetylate histones, often resulting in increased gene expression and cellular proliferation. Consequently, modulators of HAT have the potential to be promising chemotherapeutic agents, due to their ability to restrict neoplastic cellular proliferation and DNA repair.Literature suggests that resveratrol’s anti-cancerous effects are a result of its inhibition of histone deacetylases, however, despite the promising efficacy of the anti-proliferative effects documented in both in vitro and in vivo studies, the precise mechanism of action of resveratrol’s capability to suppress tumor growth is still under investigation. This study has consequently considered resveratrol from a different perspective, and has used this seemingly applicable molecule as a potential ligand for the p300-HAT enzyme and thus, has investigated its potential to modulate the p300-HAT ligand binding pocket (p300-HAT_LBP), a protein which is implicated in the epigenetic evolution of many epithelial and haematological malignancies. Superior novel inhibitors were designed through a dual-methodology, comprising of de novo and virtual screening drug design approaches.Two structures, identified through virtual screening, specifically, Chembridge_5190757 and IBS-STOCK1N-57915, and one de novo generated structure, Result_133, that satisfied all measured parameters of Lipinski rule compliance, high ligand binding affinity and predicted safety upon oral administration, were identified for optimisation and in vitrovalidation, on the premise that they hold promise as clinically useful anti-neoplastic agen

Authors and Affiliations

Rebecca Hammet, Clarie Shoemak

Keywords

Related Articles

Biological Scope of β-amino Acids and its Derivatives in Medical Fields and Biochemistry: A Review

Beta amino acids are the important macromolecules on earth and building blocks. They play key role in biological systems of living organisms. They are utilized as a part of arrangement for the most part pharmaceuticals....

Mediation of the Anticancer Effects of Resveratrol via the Upregulation of Tristetraprolin in Gastric Cancer Cell

Tristetraprolin (TTP) is an mRNA-binding protein that can induce mRNA degradation. It controls cell growth and factors related to tumor development by binding AU-rich elements located in the 3' untranslated region (UTR)...

One-Pot Synthesis of Novel Substituted Phenyl-1,5-dihydro-2Hbenzo[ 4,5]thiazolo[3,2-a]pyrimido[4,5-d]pyrimidine Derivatives as Potent Antimicrobial Agents

In this paper, we have reported the synthesis of novel substituted phenyl-1,5-dihydro-2H-benzo[4,5]thiazolo[3,2-a]pyrimido[4,5-d]pyrimidine derivatives (4a-m). The title compounds were synthesized by the react...

The Potential Inhibitors in Traditional Chinese Medicine for BCR-ABL T315I Mutation of Chronic Myelogenous Leukemia

Chronic Myelogenous Leukemia (CML) is a myeloproliferative disorder characterized by the appearance of abnormal proliferation of white blood cells in the Philadelphia chromosome. Current drugs target ABL kinase may have...

The Use of Carboranes in Cancer Drug Development

Over the past decade, there has been a rising interest in the use of carboranes as a potential pharmacophoric moiety in the development of new drugs for the treatment of various types of cancer. The unique physical and c...

Download PDF file
  • EP ID EP673133
  • DOI -
  • Views 60
  • Downloads 0

How To Cite

Rebecca Hammet, Clarie Shoemak (2018). In Silico Design and Optimisation of Phytoalexin Resveratrol Polyphenolic Analogs as Inhibitors of Histone Acetyltransferase for the Management of Tumor Growth. UNKNOWN, 8(8), 242-249. https://europub.co.uk./articles/-A-673133